SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921739-05-000104
Filing Date
2005-05-09
Accepted
2005-05-09 10:33:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 ENCYSIVE PHARMACEUTICALS INC 13G encymay.txt SC 13G 10837
2 JOINT ACQUISTION STATEMENT jas0509.txt EX-1 6620
  Complete submission text file 0000921739-05-000104.txt   19587
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Subject) CIK: 0000887023 (see all company filings)

IRS No.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44359 | Film No.: 05810057
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE COMMERCE SQ 2005 MARKET ST PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET ST PHILADELPHIA PA 19103 2152552127
DELAWARE MANAGEMENT HOLDINGS CO INC (Filed by) CIK: 0000921739 (see all company filings)

IRS No.: 232693133 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G
SIC: 6282 Investment Advice